GRC 3886,
GRC-3886,
GRC3886,
oglemilast,
Oglemilast,
778576-62-8,
N-(3,5-Dichloropyridin-4-yl)-4-(difluoromethoxy)-8-(methylsulfonamido)dibenzo[b,d]furan-1-carboxamide,
UNII-67GXQ6WCC6,
67GXQ6WCC6,
Oglemilast [INN],
SCHEMBL220245,
C20H13Cl2F2N3O5S,
CTK8C1129,
BCP21392,
GRC 3886,
2205AC,
ANW-65937,
ZINC72266998,
CS-0844,
DB12375,
NCGC00379066-01,
HY-15178,
AX8236356,
TC-154682,
GRC 3886;GRC-3886;GRC3886,
W-5778,
N-(3,5-Dichloropyridin-4-yl)-4-(difluoromethoxy)-8-(methylsulfonamido)dibenzo[b,d]furan-1-carboxamid,
D0L8KJ,
GRC-3886,
CID11387409,
Oglemilast (oral, COPD/asthma), Glenmark,
A3679,
A15197,
N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)-8-methanesulfonamido-dibenzofuran-1-carboxamide,